Ono Pharmaceutical Co., Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Ono Pharmaceutical Co., Ltd.'s past years’ income statements indicate that its last revenue has increased compared to the previous period by 12% to $502,672,000,000. The net income raised on $127,977,000,000 and profit margin reached 25%. Total operating expenses were $212,443,000,000.

Profit Margin

Ono Pharmaceutical Co., Ltd. (OTC:OPHLF): Profit margin
2015 135.77B 12.97B 9.56%
2016 160.28B 24.97B 15.58%
2017 244.79B 55.79B 22.79%
2018 261.83B 50.28B 19.2%
2019 288.63B 51.53B 17.86%
2020 292.42B 59.70B 20.42%
2021 309.28B 75.42B 24.39%
2022 361.36B 80.51B 22.28%
2023 447.18B 112.72B 25.21%
2024 502.67B 127.97B 25.46%

OPHLF Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
502.67B447.18B361.36B309.28B292.42B288.63B261.83B244.79B160.28B135.77B
Cost of revenue
127.12B110.06B93.51B85.57B79.06B83.82B65.39B65.52B41.52B35.13B
Gross profit
375.54B337.12B267.85B223.71B213.35B204.80B196.44B179.27B118.76B100.63B
Operating exp.
Research and development
112.37B95.34B75.87B62.38B66.49B70.00B68.82B57.50B43.36B41.34B
Selling and marketing
24.01B17.83B11.49B6.90B5.77B002.88B01.09B
Total operating expenses
212.44B195.16B164.65B125.38B135.86B142.79B135.76B106.98B88.25B85.84B
Operating income
163.10B141.96B103.19B98.33B77.49B62.01B60.68B72.28B30.50B14.79B
Other income (expenses), net
631M-8.76B1.83B2.56B516M3.13B3.23B14.82B2.76B1.23B
Income before tax
163.73B143.53B105.02B100.89B79.69B65.14B63.92B74.54B33.27B18.30B
Income tax expense
35.69B30.61B24.34B25.39B19.80B13.46B13.52B18.50B8.08B5.08B
Net income
127.97B112.72B80.51B75.42B59.70B51.53B50.28B55.79B24.97B12.97B
Earnings per share
Basic EPS
266.57230.85162.19151.11118.47100.2597105.2747.134.9
Diluted EPS
266.6230.79162.16151.09118.45100.2496.99105.2647.134.9